Discontinuation report JETREA
Report ID | 109082 |
Drug Identification Number | 02452154 |
Brand name | JETREA |
Common or Proper name | Solution for Intravitreal Injection |
Company Name | THROMBOGENICS NV |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | OCRIPLASMIN |
Strength(s) | 1.25MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVITREAL |
Packaging size | 0.3mL |
ATC code | S01XA |
ATC description | OTHER OPHTHALMOLOGICALS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2020-03-10 |
Remaining supply date | 2020-03-10 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | GASTON GEENSLAAN 1 LEUVEN, FLEMISH BRABANT BELGIUM 3001 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-03-20 | English | Compare |
v2 | 2020-03-20 | English | Compare |
v3 | 2020-03-20 | English | Compare |
v4 | 2020-03-20 | French | Compare |
Showing 1 to 4 of 4